Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 23 | 2021 | 1536 | 3.690 |
Why?
|
| Medication Adherence | 4 | 2021 | 335 | 1.680 |
Why?
|
| Social Support | 8 | 2018 | 423 | 1.420 |
Why?
|
| Cancer Survivors | 4 | 2020 | 146 | 1.280 |
Why?
|
| Treatment Adherence and Compliance | 2 | 2017 | 8 | 1.140 |
Why?
|
| Telecommunications | 4 | 2017 | 31 | 1.030 |
Why?
|
| Attitude to Health | 4 | 2017 | 403 | 1.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2020 | 99 | 0.910 |
Why?
|
| Interpersonal Relations | 3 | 2021 | 209 | 0.880 |
Why?
|
| Patient Selection | 5 | 2018 | 592 | 0.870 |
Why?
|
| Spirituality | 2 | 2021 | 38 | 0.870 |
Why?
|
| Forgiveness | 1 | 2021 | 1 | 0.790 |
Why?
|
| Survivorship | 1 | 2021 | 20 | 0.760 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 63 | 0.760 |
Why?
|
| Self-Help Groups | 3 | 2012 | 38 | 0.750 |
Why?
|
| Social Marketing | 3 | 2010 | 33 | 0.710 |
Why?
|
| Neoplasms | 4 | 2021 | 1667 | 0.700 |
Why?
|
| Adaptation, Psychological | 6 | 2021 | 447 | 0.680 |
Why?
|
| Evidence-Based Practice | 2 | 2019 | 146 | 0.660 |
Why?
|
| Mental Health | 1 | 2021 | 278 | 0.650 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 331 | 0.630 |
Why?
|
| Health Care Costs | 1 | 2021 | 346 | 0.620 |
Why?
|
| Psychotherapy, Group | 2 | 2011 | 55 | 0.610 |
Why?
|
| Quality of Life | 5 | 2016 | 1515 | 0.600 |
Why?
|
| Mobile Applications | 1 | 2019 | 138 | 0.600 |
Why?
|
| Religion | 2 | 2016 | 23 | 0.580 |
Why?
|
| Health Literacy | 4 | 2021 | 63 | 0.560 |
Why?
|
| Nursing Staff, Hospital | 1 | 2016 | 62 | 0.530 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 468 | 0.510 |
Why?
|
| Female | 31 | 2021 | 38074 | 0.500 |
Why?
|
| Prostatic Neoplasms | 3 | 2011 | 778 | 0.470 |
Why?
|
| Social Isolation | 1 | 2014 | 40 | 0.450 |
Why?
|
| Adult | 21 | 2020 | 21403 | 0.440 |
Why?
|
| Humans | 36 | 2021 | 68618 | 0.440 |
Why?
|
| Middle Aged | 22 | 2020 | 21147 | 0.440 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 442 | 0.430 |
Why?
|
| South Carolina | 9 | 2021 | 2752 | 0.430 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 2800 | 0.430 |
Why?
|
| Anxiety | 1 | 2015 | 422 | 0.400 |
Why?
|
| Models, Psychological | 2 | 2010 | 180 | 0.390 |
Why?
|
| Telemedicine | 1 | 2019 | 700 | 0.390 |
Why?
|
| Aged | 15 | 2019 | 14862 | 0.370 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 4848 | 0.360 |
Why?
|
| Women | 1 | 2010 | 40 | 0.350 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 378 | 0.330 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1070 | 0.320 |
Why?
|
| Data Collection | 1 | 2010 | 420 | 0.320 |
Why?
|
| Depression | 1 | 2015 | 943 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 931 | 0.290 |
Why?
|
| Affect | 2 | 2006 | 218 | 0.290 |
Why?
|
| Community-Based Participatory Research | 3 | 2018 | 133 | 0.280 |
Why?
|
| Exercise | 4 | 2018 | 658 | 0.270 |
Why?
|
| Lymphedema | 1 | 2005 | 6 | 0.260 |
Why?
|
| Personality Inventory | 1 | 2006 | 197 | 0.250 |
Why?
|
| Health Behavior | 2 | 2019 | 458 | 0.250 |
Why?
|
| Survivors | 3 | 2017 | 256 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 767 | 0.230 |
Why?
|
| Telephone | 1 | 2003 | 160 | 0.220 |
Why?
|
| Family Relations | 2 | 2014 | 47 | 0.210 |
Why?
|
| Psychometrics | 3 | 2017 | 514 | 0.200 |
Why?
|
| Patient Education as Topic | 3 | 2012 | 425 | 0.180 |
Why?
|
| Healthcare Disparities | 2 | 2016 | 378 | 0.180 |
Why?
|
| Drama | 1 | 2019 | 6 | 0.170 |
Why?
|
| Computers, Handheld | 1 | 2019 | 44 | 0.170 |
Why?
|
| Religion and Medicine | 1 | 2019 | 25 | 0.170 |
Why?
|
| Health Education | 2 | 2019 | 279 | 0.170 |
Why?
|
| Publication Bias | 1 | 2018 | 8 | 0.160 |
Why?
|
| Clinical Studies as Topic | 1 | 2018 | 7 | 0.160 |
Why?
|
| Social Adjustment | 2 | 2011 | 74 | 0.160 |
Why?
|
| Male | 11 | 2021 | 37321 | 0.160 |
Why?
|
| User-Computer Interface | 1 | 2019 | 230 | 0.160 |
Why?
|
| Friends | 2 | 2018 | 33 | 0.150 |
Why?
|
| Community Health Centers | 1 | 2017 | 26 | 0.150 |
Why?
|
| Prognosis | 2 | 2021 | 2093 | 0.150 |
Why?
|
| Anticipation, Psychological | 1 | 2017 | 8 | 0.150 |
Why?
|
| Safety-net Providers | 1 | 2017 | 20 | 0.150 |
Why?
|
| Community-Institutional Relations | 1 | 2017 | 59 | 0.150 |
Why?
|
| Early Detection of Cancer | 2 | 2019 | 454 | 0.150 |
Why?
|
| Culture | 2 | 2014 | 75 | 0.140 |
Why?
|
| Family | 1 | 2018 | 293 | 0.140 |
Why?
|
| Nurse-Patient Relations | 1 | 2016 | 34 | 0.140 |
Why?
|
| Schools, Medical | 1 | 2017 | 157 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2019 | 402 | 0.140 |
Why?
|
| Mammography | 1 | 2019 | 310 | 0.140 |
Why?
|
| Interviews as Topic | 1 | 2017 | 392 | 0.140 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 172 | 0.130 |
Why?
|
| Urban Population | 1 | 2017 | 255 | 0.130 |
Why?
|
| Caregivers | 2 | 2018 | 365 | 0.120 |
Why?
|
| Southeastern United States | 1 | 2015 | 281 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 180 | 0.120 |
Why?
|
| Cathexis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Taboo | 1 | 2014 | 1 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 561 | 0.110 |
Why?
|
| Gender Identity | 1 | 2014 | 47 | 0.110 |
Why?
|
| Rural Population | 1 | 2017 | 398 | 0.110 |
Why?
|
| Nurse's Role | 1 | 2014 | 66 | 0.110 |
Why?
|
| Sexual Partners | 1 | 2014 | 106 | 0.110 |
Why?
|
| Decision Making | 1 | 2016 | 410 | 0.110 |
Why?
|
| Health Status Disparities | 2 | 2017 | 326 | 0.110 |
Why?
|
| Diet | 2 | 2015 | 514 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2018 | 7029 | 0.100 |
Why?
|
| Medically Underserved Area | 1 | 2012 | 85 | 0.100 |
Why?
|
| Young Adult | 4 | 2019 | 5717 | 0.100 |
Why?
|
| Meditation | 1 | 2011 | 33 | 0.100 |
Why?
|
| Researcher-Subject Relations | 1 | 2010 | 4 | 0.090 |
Why?
|
| Nursing Evaluation Research | 1 | 2010 | 46 | 0.090 |
Why?
|
| Models, Nursing | 1 | 2010 | 23 | 0.090 |
Why?
|
| Audiovisual Aids | 1 | 2010 | 20 | 0.090 |
Why?
|
| Information Systems | 1 | 2010 | 45 | 0.090 |
Why?
|
| Research Design | 2 | 2015 | 729 | 0.090 |
Why?
|
| Cultural Competency | 1 | 2010 | 42 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1173 | 0.090 |
Why?
|
| Trust | 1 | 2010 | 75 | 0.090 |
Why?
|
| Program Development | 1 | 2010 | 240 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 446 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2010 | 502 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2012 | 581 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 955 | 0.070 |
Why?
|
| United States | 4 | 2021 | 7367 | 0.070 |
Why?
|
| Nursing Research | 1 | 2006 | 40 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2010 | 468 | 0.070 |
Why?
|
| Arm | 1 | 2005 | 59 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2018 | 369 | 0.060 |
Why?
|
| Health Promotion | 2 | 2019 | 407 | 0.060 |
Why?
|
| Social Environment | 1 | 2005 | 182 | 0.060 |
Why?
|
| Immunity | 1 | 2003 | 67 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2003 | 652 | 0.050 |
Why?
|
| Teaching Materials | 1 | 2021 | 16 | 0.050 |
Why?
|
| Comprehension | 1 | 2021 | 71 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2020 | 2358 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2077 | 0.040 |
Why?
|
| Educational Status | 1 | 2020 | 273 | 0.040 |
Why?
|
| Health Planning | 1 | 2019 | 23 | 0.040 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2019 | 16 | 0.040 |
Why?
|
| Oncology Nursing | 1 | 2019 | 24 | 0.040 |
Why?
|
| Learning | 1 | 2021 | 186 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 91 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2021 | 7277 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2019 | 156 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 219 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 390 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2017 | 24 | 0.040 |
Why?
|
| Health Priorities | 1 | 2017 | 23 | 0.040 |
Why?
|
| Nursing Theory | 1 | 2017 | 4 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2019 | 340 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2019 | 287 | 0.040 |
Why?
|
| Rural Health Services | 1 | 2017 | 101 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 338 | 0.030 |
Why?
|
| Women's Health | 1 | 2017 | 148 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 235 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 129 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2019 | 374 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2019 | 413 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 117 | 0.030 |
Why?
|
| Accelerometry | 1 | 2015 | 61 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 714 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 772 | 0.030 |
Why?
|
| Medicaid | 1 | 2016 | 302 | 0.030 |
Why?
|
| Motivation | 1 | 2017 | 561 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 244 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 330 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2007 | 0.030 |
Why?
|
| Community Networks | 1 | 2012 | 96 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2011 | 138 | 0.020 |
Why?
|
| Minority Groups | 1 | 2012 | 197 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1593 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 792 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8912 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2011 | 824 | 0.020 |
Why?
|